Based on the results obtained by this study, we recommend the use of alternative PCa-associated in vivo models based on cell lines that are also known to preserve high biomarker expression in their xenografts in vivo (e.g., LNCaP for PSMA expression and PC-3 for GRPR expression instead of transduced cell lines). The gene discussed is FOLH1; the disease is posterior cortical atrophy.